Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B

Mangia, A. ; Dalgard, O. ; Minerva, N. ; Verbaan, Hans LU ; Scotto, G. ; Bacca, D. ; Agostinacchio, E. ; Bjoro, K. ; Carretta, V. and Piazzolla, V. , et al. (2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver In Journal of Hepatology 50(Suppl 1). p.232-232
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Hepatology
volume
50
issue
Suppl 1
pages
232 - 232
publisher
Elsevier
conference name
44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver
conference location
Copenhagen, Denmark
conference dates
2009-04-22 - 2009-04-26
external identifiers
  • wos:000266384701114
ISSN
0168-8278
DOI
10.1016/S0168-8278(09)60632-2
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)
id
6a2e1a94-b2b3-4aa2-8133-dfbe400f8a4e (old id 1442027)
date added to LUP
2016-04-01 11:40:34
date last changed
2018-11-21 19:59:00
@misc{6a2e1a94-b2b3-4aa2-8133-dfbe400f8a4e,
  author       = {Mangia, A. and Dalgard, O. and Minerva, N. and Verbaan, Hans and Scotto, G. and Bacca, D. and Agostinacchio, E. and Bjoro, K. and Carretta, V. and Piazzolla, V. and Cozzolongo, R. and Romano, M. and Mottola, L. and Andriulli, A.},
  issn         = {0168-8278},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {Suppl 1},
  pages        = {232--232},
  publisher    = {Elsevier},
  series       = {Journal of Hepatology},
  title        = {RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B},
  url          = {http://dx.doi.org/10.1016/S0168-8278(09)60632-2},
  doi          = {10.1016/S0168-8278(09)60632-2},
  volume       = {50},
  year         = {2009},
}